China NMPA Drug Inspection - Shaanxi Hantang Pharmaceutical Co., Ltd. - Compound Danshen Tablets
China NMPA drug inspection for Shaanxi Hantang Pharmaceutical Co., Ltd. published October 30, 2020. Drug: Compound Danshen Tablets. On October 30, 2020, the Shaanxi Provincial Drug Administration published the tenth issue of its 2020 Drug Quality Bulle
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shaanxi Hantang Pharmaceutical Co., Ltd. published October 30, 2020. Drug: Compound Danshen Tablets. On October 30, 2020, the Shaanxi Provincial Drug Administration published the tenth issue of its 2020 Drug Quality Bulle
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox